Notch-mediated repression of miR-223 contributes to IGF1R regulation in T-ALL
- PMID: 22424712
- DOI: 10.1016/j.leukres.2012.02.013
Notch-mediated repression of miR-223 contributes to IGF1R regulation in T-ALL
Abstract
To identify microRNAs regulated by oncogenic Notch signaling, we performed microarray-based miRNA profiling of T-cell acute lymphoblastic leukemia (T-ALL) cells before and after treatment with γ-secretase inhibitor (GSI) to block Notch signaling. We show miR-223 levels increase after GSI treatment suggesting that active Notch signaling represses miR-223 expression. We also demonstrate that insulin-like growth factor-1 receptor (IGF1R) is regulated by miR-223 in this context, but observe no apparent effects on cell growth by overexpression or knock-down of miR-223 alone. We conclude that miR-223 contributes to IGF1R regulation, but may act in concert with other genes and/or microRNAs to alter T-ALL biology.
Crown Copyright © 2012. Published by Elsevier Ltd. All rights reserved.
Similar articles
-
Inhibition of NOTCH signaling by gamma secretase inhibitor engages the RB pathway and elicits cell cycle exit in T-cell acute lymphoblastic leukemia cells.Cancer Res. 2009 Apr 1;69(7):3060-8. doi: 10.1158/0008-5472.CAN-08-4295. Epub 2009 Mar 24. Cancer Res. 2009. PMID: 19318552
-
Notch-1 regulates Akt signaling pathway and the expression of cell cycle regulatory proteins cyclin D1, CDK2 and p21 in T-ALL cell lines.Leuk Res. 2009 May;33(5):678-85. doi: 10.1016/j.leukres.2008.10.026. Epub 2008 Dec 17. Leuk Res. 2009. PMID: 19091404
-
MicroRNA profiling reveals aberrant microRNA expression in adult ETP-ALL and functional studies implicate a role for miR-222 in acute leukemia.Leuk Res. 2013 Jun;37(6):647-56. doi: 10.1016/j.leukres.2013.02.019. Epub 2013 Mar 20. Leuk Res. 2013. PMID: 23522449
-
Notch in T-ALL: new players in a complex disease.Trends Immunol. 2011 Sep;32(9):434-42. doi: 10.1016/j.it.2011.06.005. Epub 2011 Jul 19. Trends Immunol. 2011. PMID: 21775206 Review.
-
Recent advances on NOTCH signaling in T-ALL.Curr Top Microbiol Immunol. 2012;360:163-82. doi: 10.1007/82_2012_232. Curr Top Microbiol Immunol. 2012. PMID: 22673746 Review.
Cited by
-
Type I insulin-like growth factor receptor signaling in hematological malignancies.Oncotarget. 2017 Jan 3;8(1):1814-1844. doi: 10.18632/oncotarget.12123. Oncotarget. 2017. PMID: 27661006 Free PMC article. Review.
-
Decreased expression of microRNA-223 promotes cell proliferation in hepatocellular carcinoma cells via the insulin-like growth factor-1 signaling pathway.Exp Ther Med. 2018 May;15(5):4325-4331. doi: 10.3892/etm.2018.5929. Epub 2018 Mar 6. Exp Ther Med. 2018. PMID: 29725374 Free PMC article.
-
[Expression of microRNA-191 in T lymphoblastic leukemia/lymphoma and its underlying mechanism].Zhonghua Xue Ye Xue Za Zhi. 2016 Apr;37(4):273-7. doi: 10.3760/cma.j.issn.0253-2727.2016.04.003. Zhonghua Xue Ye Xue Za Zhi. 2016. PMID: 27093985 Free PMC article. Chinese.
-
Notch Partners in the Long Journey of T-ALL Pathogenesis.Int J Mol Sci. 2023 Jan 10;24(2):1383. doi: 10.3390/ijms24021383. Int J Mol Sci. 2023. PMID: 36674902 Free PMC article. Review.
-
A parallel-arm phase I trial of the humanised anti-IGF-1R antibody dalotuzumab in combination with the AKT inhibitor MK-2206, the mTOR inhibitor ridaforolimus, or the NOTCH inhibitor MK-0752, in patients with advanced solid tumours.Br J Cancer. 2014 Nov 11;111(10):1932-44. doi: 10.1038/bjc.2014.497. Epub 2014 Oct 7. Br J Cancer. 2014. PMID: 25290091 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases